Dow Jones U.S. Pharmaceuticals Index

D.J. US Pharmaceutical Top 10: Value Investment Strategy

TOP 10 Value	INDUSTRY	VALUE	GROWTH	SAFETY	COMBINED
1. Phibro Animal Healthoration (S, US)	Pharmaceuticals	84	30	21	38
2. Pfizer (XL, US)	Pharmaceuticals	46	52	63	61
3. AbbVie (XXL, US) ☀	Biotechnology	46	73	8	34
4. Akorn (M, US)	Pharmaceuticals	38	23	43	20
5. Lannett (S, US)	Pharmaceuticals	38	43	21	20

April 28, 2017. Top 10s are published weekly by Top 10 schedule. (Free Stock Update)

TOP 10 Growth	INDUSTRY	VALUE	GROWTH	SAFETY	COMBINED
1. Supernus Pharma (S, US)	Pharmaceuticals	19	100	53	66
2. Bristol-Myers Squibb (XXL, US) ☀	Pharmaceuticals	34	78	92	91
3. AbbVie (XXL, US) ☀	Biotechnology	46	73	8	34
4. Johnson & Johnson (XL, US) ☀	Pharmaceuticals	35	66	26	31
5. Pfizer (XL, US)	Pharmaceuticals	46	52	63	61
6. Prestige (M, US)	Pharmaceuticals	4	52	17	3

April 28, 2017. Top 10s are published weekly by Top 10 schedule. (Free Stock Update)

TOP 10 Safety	INDUSTRY	VALUE	GROWTH	SAFETY	COMBINED
1. Bristol-Myers Squibb (XXL, US) ☀	Pharmaceuticals	34	78	92	91
2. Merck (XL, US) ☀	Pharmaceuticals	20	27	77	28
3. Eli Lilly (XL, US) ☀	Pharmaceuticals	18	28	68	25
4. Pfizer (XL, US)	Pharmaceuticals	46	52	63	61
5. Supernus Pharma (S, US)	Pharmaceuticals	19	100	53	66

April 28, 2017. Top 10s are published weekly by Top 10 schedule. (Free Stock Update)

TOP 10 Combined	INDUSTRY	VALUE	GROWTH	SAFETY	COMBINED
1. Bristol-Myers Squibb (XXL, US) ☀	Pharmaceuticals	34	78	92	91
2. Supernus Pharma (S, US)	Pharmaceuticals	19	100	53	66
3. Pfizer (XL, US)	Pharmaceuticals	46	52	63	61
4. Phibro Animal Healthoration (S, US)	Pharmaceuticals	84	30	21	38
5. AbbVie (XXL, US) ☀	Biotechnology	46	73	8	34

April 28, 2017. Top 10s are published weekly by Top 10 schedule. (Free Stock Update)

☀ This company has a special achievement which is documented on its stock research page.

Top 10 lists may contain fewer then 10 stocks due to Obermatt’s top 10 quality standards.

Top 10 Stocks from the purely finance fact-based Obermatt Method for the investment strategies Value, Growth and Safety in the stock index Dow Jones U.S. Pharmaceuticals Index from April 28, 2017.